n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid has been researched along with Iron Overload in 6 studies
*Iron Overload: An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Knutson, M; Lavin, SR; Livingston, S; Sullivan, KE; Valdes, EV; Warren, LK | 1 |
| Hider, RC; Tilbrook, GS | 1 |
| Bergeron, RJ; Brittenham, GM; Wiegand, J | 3 |
| Hershko, C; Konijn, AM; Link, G | 1 |
2 review(s) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and Iron Overload
| Article | Year |
|---|---|
Iron chelators for clinical use.
Topics: Biological Transport; Deferoxamine; Drug Delivery Systems; Edetic Acid; Ferric Compounds; Free Radical Scavengers; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Molecular Weight; Oxidation-Reduction; Pentetic Acid; Razoxane; Solubility; Structure-Activity Relationship; Tissue Distribution | 1998 |
Iron chelators for thalassaemia.
Topics: Administration, Oral; Aza Compounds; Chelating Agents; Deferiprone; Deferoxamine; Edetic Acid; Humans; Iron; Iron Chelating Agents; Iron Overload; Long-Term Care; Pyridones; Thalassemia | 1998 |
1 trial(s) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and Iron Overload
| Article | Year |
|---|---|
Safety and efficacy of a novel iron chelator (HBED; (N,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid)) in equine (Equus caballus) as a model for black rhinoceros (Diceros bicornis).
Topics: Acetates; Animals; Edetic Acid; Ethylenediamines; Horse Diseases; Horses; Iron; Iron Chelating Agents; Iron Overload; Perissodactyla | 2022 |
3 other study(ies) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and Iron Overload
| Article | Year |
|---|---|
HBED: A potential alternative to deferoxamine for iron-chelating therapy.
Topics: Animals; Antidotes; Chelating Agents; Deferoxamine; Edetic Acid; Haplorhini; Iron Overload; Male; Rats; Rats, Sprague-Dawley; Transfusion Reaction | 1998 |
HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.
Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Edetic Acid; Injections, Intravenous; Injections, Subcutaneous; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Rats; Rats, Sprague-Dawley | 1999 |
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning.
Topics: Acute Disease; Animals; Blood Pressure; Cebus; Chronic Disease; Deferoxamine; Disease Models, Animal; Dogs; Drug Administration Routes; Drug Evaluation, Preclinical; Edetic Acid; Heart Rate; Iron; Iron Chelating Agents; Iron Overload; Male; Poisoning; Rats; Rats, Sprague-Dawley; Therapeutic Equivalency | 2002 |